Anthony A. DiTonno
2021
In 2021, Anthony A. DiTonno earned a total compensation of $1.1M as Former Chief Executive Officer at Tenax Therapeutics, a 44% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $119,952 |
|---|---|
| Option Awards | $215,455 |
| Salary | $262,056 |
| Other | $462,108 |
| Total | $1,059,571 |
DiTonno received $462.1K in other compensation, accounting for 44% of the total pay in 2021.
DiTonno also received $120K in non-equity incentive plan, $215.5K in option awards and $262.1K in salary.
Rankings
In 2021, Anthony A. DiTonno's compensation ranked 8,602nd out of 12,415 executives tracked by ExecPay. In other words, DiTonno earned more than 30.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,602 out of 12,415 | 31st |
Division Manufacturing | 3,812 out of 5,505 | 31st |
Major group Chemicals And Allied Products | 1,685 out of 2,375 | 29th |
Industry group Drugs | 1,499 out of 2,096 | 29th |
Industry Pharmaceutical Preparations | 1,118 out of 1,546 | 28th |
Source: SEC filing on April 28, 2022.
DiTonno's colleagues
We found four more compensation records of executives who worked with Anthony A. DiTonno at Tenax Therapeutics in 2021.